Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
105 patients (estimated)
Sponsors
University of Virginia
Tags
Randomization
Trial Type
Supportive
Last Update
4 weeks ago
SparkCures ID
1549
NCT Identifier
NCT04482894

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.